Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lux

Showing results (111-120 of 233) with videos related to

Pageof 24
Sort By:
Breast Care (Basel, Switzerland)|July 12, 2021
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the GuidelinesMichael P Lux, Sonja Wasner, Julia Meyer, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2017
Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant ChemotherapyR Schulz-Wendtland, P Dankerl, M R Bani, et al.
International Journal of Cancer|July 12, 2018
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trialHans Tesch, Oliver Stoetzer, Thomas Decker, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Hormone replacement therapy and prognosis in ovarian cancer patientsAlexander Hein, Falk C Thiel, Christian M Bayer, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast CancerR Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Journal of Bone Oncology|December 6, 2018
The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trialPeyman Hadji, Oliver Stoetzer, Thomas Decker, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2010
Diabetes and prognosis in a breast cancer cohortMichael G Schrauder, Peter A Fasching, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkP A Fasching, S Y Brucker, T N Fehm, et al.
International Journal of Cancer|July 9, 2016
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammographyLothar Häberle, Peter A Fasching, Barbara Brehm, et al.
Pageof 24

Showing results (111-120 of 233) with videos related to

Sort By:
Pageof 24
Breast Care (Basel, Switzerland)|July 12, 2021
Analysis of Oncological Second Opinions in a Certified University Breast and Gynecological Cancer Center Regarding Consensus between the First and Second Opinion and Conformity with the GuidelinesMichael P Lux, Sonja Wasner, Julia Meyer, et al.
Geburtshilfe Und Frauenheilkunde|March 24, 2017
Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant ChemotherapyR Schulz-Wendtland, P Dankerl, M R Bani, et al.
International Journal of Cancer|July 12, 2018
Efficacy and safety of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative locally advanced or metastatic breast cancer: Results of the single-arm, phase IIIB 4EVER trialHans Tesch, Oliver Stoetzer, Thomas Decker, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Hormone replacement therapy and prognosis in ovarian cancer patientsAlexander Hein, Falk C Thiel, Christian M Bayer, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
Evaluation of Newly Adapted Clip Marker System in Ultrasound-Guided Core Needle Biopsy for Suspicion of Breast CancerR Schulz-Wendtland, P Dankerl, G Dilbat, et al.
Journal of Bone Oncology|December 6, 2018
The impact of mammalian target of rapamycin inhibition on bone health in postmenopausal women with hormone receptor-positive advanced breast cancer receiving everolimus plus exemestane in the phase IIIb 4EVER trialPeyman Hadji, Oliver Stoetzer, Thomas Decker, et al.
Breast Cancer Research and Treatment|August 31, 2012
Shared decision-making in breast cancer: discrepancy between the treatment efficacy required by patients and by physiciansFalk C Thiel, Michael G Schrauder, Peter A Fasching, et al.
Journal of Cancer Research and Clinical Oncology|December 7, 2010
Diabetes and prognosis in a breast cancer cohortMichael G Schrauder, Peter A Fasching, Lothar Häberle, et al.
Geburtshilfe Und Frauenheilkunde|February 17, 2015
Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study NetworkP A Fasching, S Y Brucker, T N Fehm, et al.
International Journal of Cancer|July 9, 2016
Mammographic density is the main correlate of tumors detected on ultrasound but not on mammographyLothar Häberle, Peter A Fasching, Barbara Brehm, et al.
Pageof 24